Interferon-α treatment results in a decrease in the number of activated HSCs in the liver tissues of patients with chronic hepatitis B [51], and it was also reported that AP-1-dependent genes are increased in sera from HBV-infected individuals after interferon-α treatment [52]. This evidence concerns the gene JUN and chronic hepatitis B virus infection.